We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+19.62%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.49B
AUM Growth
+$793M
Cap. Flow
+$371M
Cap. Flow %
8.27%
Top 10 Hldgs %
26.42%
Holding
1,074
New
214
Increased
261
Reduced
300
Closed
292

Sector Composition

Rank Sector Weight
1 Healthcare 19.87%
2 Technology 14.15%
3 Consumer Discretionary 9.75%
4 Industrials 6.31%
5 Energy 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSIC icon
426
Henry Schein
HSIC
$9.83B
$2.24M 0.05%
+55,111
New +$2.23M
HNP
427
DELISTED
Huaneng Power Intl, Inc.
HNP
$2.24M 0.05%
55,888
+22,708
+68% +$919K
PCRX icon
428
Pacira BioSciences
PCRX
$997M
$2.22M 0.05%
46,071
-80,051
-63% -$2.92M
WAL icon
429
Western Alliance Bancorporation
WAL
$8.86B
$2.21M 0.05%
+116,921
New +$2.04M
AMSG
430
DELISTED
Amsurg Corp
AMSG
$2.2M 0.05%
55,413
-3,308
-6% -$128K
VSI
431
DELISTED
Vitamin Shoppe Inc.
VSI
$2.19M 0.05%
50,070
-52,060
-51% -$2.3M
NDZ
432
DELISTED
NORDION INC COM STK (CDA)
NDZ
$2.18M 0.05%
252,558
+41,137
+19% +$321K
SHO icon
433
Sunstone Hotel Investors
SHO
$2.07B
$2.15M 0.05%
+169,190
New +$2.16M
DAR icon
434
Darling Ingredients
DAR
$9.43B
$2.15M 0.05%
101,566
-148,921
-59% -$3.04M
CRAY
435
DELISTED
Cray, Inc.
CRAY
$2.14M 0.05%
+88,957
New +$2.17M
OME
436
DELISTED
Omega Protein
OME
$2.14M 0.05%
210,001
-35,281
-14% -$330K
CLVS
437
DELISTED
Clovis Oncology, Inc.
CLVS
$2.13M 0.05%
35,115
-34,278
-49% -$2.43M
ACGL icon
438
Arch Capital
ACGL
$33.6B
$2.13M 0.05%
118,083
-104,262
-47% -$1.86M
SRDX
439
DELISTED
Surmodics
SRDX
$2.13M 0.05%
89,606
-56,288
-39% -$1.21M
DEG
440
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
$2.13M 0.05%
134,912
+72,904
+118% +$1.19M
SFLY
441
DELISTED
Shutterfly, Inc.
SFLY
$2.13M 0.05%
38,053
-59,266
-61% -$3.3M
DRIV
442
DELISTED
DIGITAL RIVER INC.
DRIV
$2.11M 0.05%
118,326
-67,674
-36% -$1.22M
ECHO
443
EchoStar
ECHO
$26.2B
$2.1M 0.05%
58,937
-193,618
-77% -$6.55M
DCM
444
DELISTED
NTT DOCOMO, Inc.
DCM
$2.09M 0.05%
128,918
+26,823
+26% +$426K
CHA
445
DELISTED
China Telecom Corporation, LTD
CHA
$2.09M 0.05%
42,285
+31,492
+292% +$1.6M
CACC icon
446
Credit Acceptance
CACC
$6.06B
$2.09M 0.05%
+18,855
New +$2.09M
NSU
447
DELISTED
Nevsun Resources Ltd.
NSU
$2.08M 0.05%
656,872
+636,368
+3,104% +$2.06M
RCI icon
448
Rogers Communications
RCI
$18.6B
$2.07M 0.05%
48,074
+18,747
+64% +$762K
SCOR icon
449
Comscore
SCOR
$112M
$2.06M 0.05%
3,563
-745
-17% -$415K
FWLT
450
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$2.06M 0.05%
78,156
+66,401
+565% +$1.55M

Similar funds

Oxford Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, Oxford Asset Management held 1,074 positions worth $4.49B, up 21% from $3.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Oxford Asset Management deployed $371M of net new capital in Q3 2013, opening 214 new positions and adding to 261 existing holdings. Its largest new stake was ONYX PHARMACEUTICALS INC: 950,000 shares worth $118M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Akamai, an estimated $15.8M trimmed.

  • Oxford Asset Management's largest Q3 2013 buy was ONYX PHARMACEUTICALS INC: 950,000 shares worth $118M.
  • Oxford Asset Management added most to ELAN CORP ADS(RP1 ORD4IRISH PN in Q3 2013, an estimated $383M increase.
  • Oxford Asset Management's biggest Q3 2013 reduction was Akamai, cutting an estimated $15.8M.
  • Oxford Asset Management fully exited BMC SOFTWARE, INC in Q3 2013, selling an estimated $123M.
  • Oxford Asset Management's ten largest holdings make up 26% of its $4.49B portfolio in Q3 2013.
  • Oxford Asset Management opened 214 new positions and closed 292 in Q3 2013.
  • Oxford Asset Management's portfolio value rose 21% quarter-over-quarter to $4.49B.

Based on Oxford Asset Management's 13F filing for Q3 2013, filed 16 Oct 2013.